Earnings call transcript: Cameco misses Q3 2026 estimates as shares fall

Cameco reported Q3 2026 adjusted EPS of $0.0703 versus $0.23 expected and revenue of $434.97 million versus $528.33 million expected; shares fell 7.88% to $76.91 in regular trading. The company narrowed 2026 uranium production guidance to 19.5–20.5 million pounds and deliveries to 29.5–30.5 million pounds, citing planned Key Lake maintenance and higher input costs, while reducing capital expenditure guidance. Management maintained the CAD 0.24 annual dividend and described uranium fundamentals and long-term contracting prospects as constructive, but the near-term earnings shortfall dominated the market reaction.

Analysis

The key risk is not whether uranium demand is structurally attractive; it is the timing mismatch between that thesis and Cameco’s earnings conversion. Contract discipline can preserve future pricing power, but it also means higher uranium prices and utility urgency do not translate immediately into reported volumes or cash flow. The quarter therefore exposes a two-part valuation vulnerability: investors may reduce the execution premium now, while the fundamental thesis takes several quarters to validate through contracting and reliable output. Planned maintenance is a plausible explanation, not proof that cost pressure is temporary; the next evidence is post-outage production and unit-cost normalization. The reduced capex outlook may support near-term cash generation, but project deferrals also push out capacity and fuel-cycle growth.\n\nContrarian point: the long-term supply thesis is not yet a near-term earnings catalyst. Management’s contracting commentary is constructive, but cited terms apply to small volumes; watch signed contract volumes and realized pricing rather than headline floors and ceilings. A material reversal in the bull case would require either contracting recovering to replacement levels without stronger prices, credible new supply arriving on schedule, or a prolonged operating-cost/production problem. Conversely, recovery in output and costs alongside stronger contracting would restore the case that this is timing noise rather than deteriorating execution.

Key Decisions for Investors

• Do not chase an outright short after the sharp selloff: the stock is already near its stated 52-week low, while the supply thesis and limited net debt constrain the downside case. Wait for post-outage operating data before adding to a long.
• For a tactical long, scale in only after CCO holds the $73.89–$76 area and the next operating update confirms production recovery and easing unit costs. A decisive break below $73.89, or further cost/guidance deterioration, falsifies that stabilization setup; do not treat the level as a guaranteed floor.
• Over the next 1–3 months, track signed long-term uranium contracting volumes and disclosed realized pricing. Treat management’s price indications as directional until supported by larger contracted volumes; improving contract terms without replacement-rate volumes is not yet an earnings inflection.
• Keep any uranium exposure diversified rather than underwriting CCO solely on AI or new-build announcements. Reassess over 6–18 months against utility contracting, production reliability, and whether deferred projects return to schedule; no incremental trade is warranted if those indicators remain unverified.